Image fusion techniques in permanent seed implantation

Journal of Contemporary Brachytherapy

Volumn 2, Issue 3, 2010, Pages 98-106

  Polo, Alfredo ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Brachytherapy; Image fusion; Prostate cancer; Seeds

Indexed keywords

BRACHYTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DOPPLER ECHOGRAPHY; DOSE CALCULATION; FLUOROSCOPY; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INTRAOPERATIVE PERIOD; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; REVIEW;

EID: 78049488260     PISSN: 1689832X     EISSN: None     Source Type: Journal    
DOI: 10.5114/jcb.2010.16920     Document Type: Review

References (80)

1. Jain AK, Zhou Y, Mustufa T et al. Matching and reconstruction of brachytherapy seeds using the Hungarian algorithm (MARSHAL). Med Phys 2005; 32: 3475-3492. (Pubitemid 41689302)
2. Han BH, Wallner K, Merrick G et al. Prostate brachytherapy seed identification on post-implant TRUS images. Med Phys 2003; 30: 898-900.
3. Xue J, Waterman F, Handler J et al. Localization of linked 125I seeds in postimplant TRUS images for prostate brachytherapy dosimetry. Int J Radiat Oncol Biol Phys 2005; 62: 912-919.
4. Penner EA. Interventional MR with a mid-field open system. In: Debatin JF (ed.). Interventional magnetic resonance imaging. Springer-Verlag, Berlin 1998; 11-18.
5. Hricak H, Jeffrey RB, Dooms GC et al. Evaluation of prostate size: a comparison of ultrasound and magnetic resonance imaging. Urol Radiol 1987; 9: 1-8.
6. Terris MK, Stamey TA. Determination of prostate volume by transrectal ultrasound. J Urol 1991; 145: 984-987.
7. Rahmouni A, Yang A, Tempany CM et al. Accuracy of in-vivo assessment of prostatic volume by MRI and transrectal ultrasonography. J Comput Assist Tomogr 1992; 16: 935-940.
8. Terris MK, McNeal JE, Stamey TA. Estimation of prostate cancer volume by transrectal ultrasound imaging. J Urol 1992; 147: 855-857.
9. al-Rimawi M, Griffiths DJ, Boake RC et al. Transrectal ultrasound versus magnetic resonance imaging in the estimation of prostatic volume. Br J Urol 1994; 74: 596-600.
10. Tewari A, Indudhara R, Shinohara K et al. Comparison of transrectal ultrasound prostatic volume estimation with magnetic resonance imaging volume estimation and surgical specimen weight in patients with benign prostatic hyperplasia. J Clin Ultrasound 1996; 24: 169-174.
11. Sosna J, Rofsky NM, Gaston SM et al. Determinations of prostate volume at 3-Tesla using an external phased array coil: comparison to pathologic specimens. Acad Radiol 2003; 10: 846-853.
12. Cormack RA, Kooy H, Tempany CM et al. A clinical method for real-time dosimetric guidance of transperineal 125I prostate implants using interventional magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2000; 46: 207-214.
13. Cormack RA, Tempany CM, D'Amico AV. Optimizing target coverage by dosimetric feedback during prostate brachytherapy. Int J Radiat Oncol Biol Phys 2000; 48: 1245-1249.
14. Polo A. Feasibility of functional imaging for brachytherapy. J Contemp Brachyth 2009; 1: 45-49.
15. Saw CB, Chen H, Beatty RE et al. Multimodality image fusion and planning and dose delivery for radiation therapy. Med Dosim 2008; 33: 149-155.
16. Bentzen SM. Theragnostic imaging for radiation oncology: dose-painting by numbers. Lancet Oncol 2005; 6: 112-117.
17. Polo A, Salembier C, Venselaar J et al. Review of intraoperative imaging and planning techniques in permanent seed prostate brachytherapy. Radiother Oncol 2010; 94: 12-23.
18. Villeirs GM, De Meerleer GO. Magnetic resonance imaging (MRI) anatomy of the prostate and application of MRI in radiotherapy planning. Eur J Radiol 2007; 63: 361-368.
19. Nimmagadda S, Ford EC, Wong JW et al. Targeted molecular imaging in oncology: focus on radiation therapy. Semin Radiat Oncol 2008; 18: 136-148.
20. Pallwein L, Mitterberger M, Pelzer A et al. Ultrasound of prostate cancer: recent advances. Eur Radiol 2008; 18: 707-715.
21. Image registration and data fusion in radiation therapy. 79 Spec No 1; 2006; The University of Michigan, Ann Arbor, MI 48103, USA 2006.
22. Image Fusion: Is It Merely the Blending of Pretty Pictures? 3(9); 2010; Cardiovascular Imaging Laboratory, Imaging Institute and Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio 2010.
23. Christensen GE, Carlson B, Chao KS et al. Image-based dose planning of intracavitary brachytherapy: registration of serial-imaging studies using deformable anatomic templates. Int J Radiat Oncol Biol Phys 2001; 51: 227-243.
24. Sharpe M, Brock KK. Quality assurance of serial 3D image registration, fusion, and segmentation. Int J Radiat Oncol Biol Phys 2008; 71: 33-37.
25. American Association of Physicists in Medicine Radiation Therapy Committee Task Group 53: quality assurance for clinical radiotherapy treatment planning. 25(10); 1998; University of Michigan Medical Center, Ann Arbor, USA. bfraass@umich.edu: 1998.
26. Phantom validation of coregistration of PET and CT for image-guided radiotherapy. 31(5); 2004; Department of Radiology and Radiological Sciences, Vanderbilt University, Nashville, Tennessee, USA.
27. Parker CC, Damyanovich A, Haycocks T et al. Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration. Radiother Oncol 2003; 66: 217-224.
28. Mutic S, Dempsey JF, Bosch WR et al. Multimodality image registration quality assurance for conformal three-dimensional treatment planning. Int J Radiat Oncol Biol Phys 2001; 51: 255-260.
29. Tanaka O, Hayashi S, Matsuo M et al. Comparison of MRI-based and CT/MRI fusion-based postimplant dosimetric analysis of prostate brachytherapy. Int J Radiat Oncol Biol Phys 2006; 66: 597-602.
30. Nag S, Beyer D, Friedland J et al. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys 1999; 44: 789-799.
31. Nag S, Bice W, DeWyngaert K et al. The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int J Radiat Oncol Biol Phys 2000; 46: 221-230.
32. Potters L, Cao Y, Calugaru E et al. A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2001; 50: 605-614.
33. Stock RG, Stone NN, Tabert A et al. A dose-response study for I-125 prostate implants. Int J Radiat Oncol Biol Phys 1998; 41: 101-108.
34. Yu Y, Anderson LL, Li Z et al. Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64. Med Phys 1999; 26: 2054-2076.
35. Bice WS, Jr., Prestidge BR, Prete JJ et al. Clinical impact of implementing the recommendations of AAPM Task Group 43 on permanent prostate brachytherapy using 125I. American Association of Physicists in Medicine. Int J Radiat Oncol Biol Phys 1998; 40: 1237-1241.
36. Wallner K, Roy J, Harrison L. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys 1995; 32: 465-471.
37. Badiozamani KR, Wallner K, Cavanagh W et al. Comparability of CT-based and TRUS-based prostate volumes. Int J Radiat Oncol Biol Phys 1999; 43: 375-378.
38. Narayana V, Roberson PL, Winfield RJ et al. Impact of ultrasound and computed tomography prostate volume registration on evaluation of permanent prostate implants. Int J Radiat Oncol Biol Phys 1997; 39: 341-346.
39. Roach M 3rd, Faillace-Akazawa P, Malfatti C et al. Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 1996; 35: 1011-1018.
40. Rosen II, Khan KM, Lane RG et al. The effect of geometric errors in the reconstruction of iridium-192 seed implants. Med Phys 1982; 9: 220-223.
41. Al-Qaisieh B, Ash D, Bottomley DM et al. Impact of prostate volume evaluation by different observers on CT-based post-implant dosimetry. Radiother Oncol 2002; 62: 267-273.
42. Lee WR, Roach M 3rd, Michalski J et al. Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy. Int J Radiat Oncol Biol Phys 2002; 54: 457-461.
43. Dubois DF, Prestidge BR, Hotchkiss LA et al. Intraobserver and interobserver variability of MR imaging- and CT-derived prostate volumes after transperineal interstitial permanent prostate brachytherapy. Radiology 1998; 207: 785-789.
44. Cazzaniga LF, Marinoni MA, Bossi A et al. Interphysician variability in defining the planning target volume in the irradiation of prostate and seminal vesicles. Radiother Oncol 1998; 47: 293-296.
45. Fiorino C, Reni M, Bolognesi A et al. Intra- and inter-observer variability in contouring prostate and seminal vesicles: implications for conformal treatment planning. Radiother Oncol 1998; 47: 285-292.
46. Valicenti RK, Sweet JW, Hauck WW et al. Variation of clinical target volume definition in three-dimensional conformal radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 1999; 44: 931-935.
47. Sandler HM, Bree RL, McLaughlin PW et al. Localization of the prostatic apex for radiation therapy using implanted markers. Int J Radiat Oncol Biol Phys 1993; 27: 915-919.
48. Kagawa K, Lee WR, Schultheiss TE et al. Initial clinical assessment of CT-MRI image fusion software in localization of the prostate for 3D conformal radiation therapy. Int J Radiat Oncol Biol Phys 1997; 38: 319-325.
49. Rasch C, Barillot I, Remeijer P et al. Definition of the prostate in CT and MRI: a multi-observer study. Int J Radiat Oncol Biol Phys 1999; 43: 57-66.
50. Merrick GS, Butler WM, Dorsey AT et al. The dependence of prostate postimplant dosimetric quality on CT volume determination. Int J Radiat Oncol Biol Phys 1999; 44: 1111-1117.
51. Lee WR, deGuzman AF, Bare RL et al. Postimplant analysis of transperineal interstitial permanent prostate brachytherapy: evidence for a learning curve in the first year at a single institution. Int J Radiat Oncol Biol Phys 2000; 46: 83-88.
52. Bice WS, Jr., Prestidge BR, Grimm PD et al. Centralized multiinstitutional postimplant analysis for interstitial prostate brachytherapy. Int J Radiat Oncol Biol Phys 1998; 41: 921-927.
53. Moerland MA, Wijrdeman HK, Beersma R et al. Evaluation of permanent I-125 prostate implants using radiography and magnetic resonance imaging. Int J Radiat Oncol Biol Phys 1997; 37: 927-933.
54. Dubois DF, Prestidge BR, Hotchkiss LA et al. Source localization following permanent transperineal prostate interstitial brachytherapy using magnetic resonance imaging. Int J Radiat Oncol Biol Phys 1997; 39: 1037-1041.
55. Prete JJ, Prestidge BR, Bice WS et al. Comparison of MRI- and CT-based post-implant dosimetric analysis of transperineal interstitial permanent prostate brachytherapy. Radiat Oncol Investig 1998; 6: 90-96.
56. Amdur RJ, Gladstone D, Leopold KA et al. Prostate seed implant quality assessment using MR and CT image fusion. Int J Radiat Oncol Biol Phys 1999; 43: 67-72.
57. Narayana V, Roberson PL, Pu AT et al. Impact of differences in ultrasound and computed tomography volumes on treatment planning of permanent prostate implants. Int J Radiat Oncol Biol Phys 1997; 37: 1181-1185. (Pubitemid 27230045)
58. McLaughlin PW, Narayana V, Drake DG et al. Comparison of MRI pulse sequences in defining prostate volume after permanent implantation. Int J Radiat Oncol Biol Phys 2002; 54: 703-711.
59. Milosevic M, Voruganti S, Blend R et al. Magnetic resonance imaging (MRI) for localization of the prostatic apex: comparison to computed tomography (CT) and urethrography. Radiother Oncol 1998; 47: 277-284.
60. Debois M, Oyen R, Maes F et al. The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer. Int J Radiat Oncol Biol Phys 1999; 45: 857-865.
61. Polo A, Cattani F, Vavassori A et al. MR and CT image fusion for postimplant analysis in permanent prostate seed implants. Int J Radiat Oncol Biol Phys 2004; 60: 1572-1579.
62. Taussky D, Austen L, Toi A et al. Sequential evaluation of prostate edema after permanent seed prostate brachytherapy using CT-MRI fusion. Int J Radiat Oncol Biol Phys 2005; 62: 974-980.
63. Crook J, McLean M, Yeung I et al. MRI-CT fusion to assess postbrachytherapy prostate volume and the effects of prolonged edema on dosimetry following transperineal interstitial permanent prostate brachytherapy. Brachytherapy 2004; 3: 55-60.
64. Speight JL, Shinohara K, Pickett B et al. Prostate volume change after radioactive seed implantation: possible benefit of improved dose volume histogram with perioperative steroid. Int J Radiat Oncol Biol Phys 2000; 48: 1461-1467.
65. Nag S, Ciezki JP, Cormack R et al. Intraoperative planning and evaluation of permanent prostate brachytherapy: report of the American Brachytherapy Society. Int J Radiat Oncol Biol Phys 2001; 51: 1422-1430.
66. Sahgal A, Roach Mr. Permanent prostate seed brachytherapy: a current perspective on the evolution of the technique and its application. Nat Clin Pract Urol 2007; 4: 658-670.
67. Todor DA, Zaider M, Cohen GN et al. Intraoperative dynamic dosimetry for prostate implants. Phys Med Biol 2003; 48: 1153-1171.
68. Lee EK, Zaider M. Intraoperative dynamic dose optimization in permanent prostate implants. Int J Radiat Oncol Biol Phys 2003; 56: 854-861. (Pubitemid 36677382)
69. Su Y, Davis BJ, Herman MG et al. TRUS-fluoroscopy fusion for intraoperative prostate brachytherapy dosimetry. Stud Health Technol Inform 2006; 119: 532-537.
70. Su Y, Davis BJ, Furutani KM et al. Seed localization and TRUS-fluoroscopy fusion for intraoperative prostate brachytherapy dosimetry. Comput Aided Surg 2007; 12: 25-34.
71. French D, Morris J, Keyes M et al. Computing intraoperative dosimetry for prostate brachytherapy using TRUS and fluoroscopy. Acad Radiol 2005; 12: 1262-1272.
72. Gong L, Cho PS, Han BH et al. Ultrasonography and fluoroscopic fusion for prostate brachytherapy dosimetry. Int J Radiat Oncol Biol Phys 2002; 54: 1322-1330.
73. Su Y, Davis BJ, Herman MG et al. Prostate brachytherapy seed localization by analysis of multiple projections: identifying and addressing the seed overlap problem. Med Phys 2004; 31: 1277-1287.
74. Siewerdsen JH, Moseley DJ, Burch S et al. Volume CT with a flat-panel detector on a mobile, isocentric C-arm: pre-clinical investigation in guidance of minimally invasive surgery. Med Phys 2005; 32: 241-254.
75. Jaffray DA, Siewerdsen JH, Edmundson GK et al. Flat-panel cone-beam CT on a mobile isocentric C-arm for image-guided brachytherapy. Proceedings of SPIE 2002; 4682: 209-217.
76. Siewerdsen JH, Daly MJ, Bachar G et al. Multimode C-arm fluoroscopy, tomosynthesis, and cone-beam CT for image-guided interventions: from proof of principle to patient protocols. Proceedings of SPIE 2007; 6510: 65101A-651011.
77. Westendorp H, Hoekstra CJ, van't Riet A et al. Intraoperative adaptive brachytherapy of iodine-125 prostate implants guided by C-arm cone-beam computed tomography-based dosimetry. Brachytherapy 2007; 6: 231-237.
78. Grégoire V, Haustermans K, Geets X et al. PET-Based Treatment Planning in Radiotherapy: A New Standard? J Nucl Med 2007; 48: 68-77.
79. Saleem A. Potential of PET in oncology and radiotherapy. Brit J Radiol 2005; Suppl 28: 6-16.
80. Ling CC, Humm J, Larson S et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 2000; 47: 551-560.